Suppr超能文献

容量负荷、多巴酚丁胺和硝普钠对以右心室梗死为主的患者的比较效应

Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction.

作者信息

Dell'Italia L J, Starling M R, Blumhardt R, Lasher J C, O'Rourke R A

出版信息

Circulation. 1985 Dec;72(6):1327-35. doi: 10.1161/01.cir.72.6.1327.

Abstract

To assess the value of volume loading and to determine the relative efficacy of dobutamine compared with nitroprusside therapy in acute right ventricular infarction (RVMI), 13 patients with clinical, hemodynamic, and radionuclide angiographic evidence of RVMI were evaluated. In 10 patients who had an initial pulmonary arterial wedge pressure less than 18 mm Hg, volume loading did not improve cardiac index (1.9 +/- 0.5 [SD] to 2.1 +/- 0.4 liters/min/m2), despite significant increases in mean right atrial pressure (11 +/- 2 to 15 +/- 2 mm Hg, p less than .001) and pulmonary arterial wedge pressure (10 +/- 4 to 15 +/- 2 mm Hg, p less than .001). Nine patients received dobutamine or nitroprusside in random order, while hemodynamic measurements and radionuclide angiograms were obtained simultaneously. Compared with nitroprusside, dobutamine produced a statistically significant increase in cardiac index (2.0 +/- 0.4 to 2.7 +/- 0.5 vs 2.1 +/- 0.4 to 2.3 +/- 0.5 liters/min/m2, p less than .001), stroke volume index (29 +/- 6 to 36 +/- 8 vs 29 +/- 6 to 30 +/- 6 ml/m2, p = .02), and right ventricular ejection fraction (30 +/- 8% to 42 +/- 7% vs 34 +/- 8% to 37 +/- 4%, p less than .01) by two-way analysis of variance. We conclude that volume loading does not improve cardiac index in patients with acute RVMI despite a rise in cardiac filling pressures and that infusion of dobutamine, after appropriate volume loading, produces a significant improvement in cardiac index and right ventricular ejection fraction over those after infusion of nitroprusside.

摘要

为评估容量负荷的价值,并确定多巴酚丁胺与硝普钠治疗急性右心室心肌梗死(RVMI)的相对疗效,我们对13例有临床、血流动力学及放射性核素血管造影证据的RVMI患者进行了评估。10例初始肺动脉楔压低于18 mmHg的患者,尽管平均右心房压显著升高(从11±2 mmHg升至15±2 mmHg,p<0.001)和肺动脉楔压显著升高(从10±4 mmHg升至15±2 mmHg,p<0.001),但容量负荷并未改善心脏指数(从1.9±0.5[标准差]升至2.1±0.4升/分钟/平方米)。9例患者随机接受多巴酚丁胺或硝普钠治疗,同时进行血流动力学测量和放射性核素血管造影。通过双向方差分析,与硝普钠相比,多巴酚丁胺使心脏指数有统计学显著升高(从2.0±0.4升至2.7±0.5,而硝普钠组从2.1±0.4升至2.3±0.5升/分钟/平方米,p<0.001),每搏量指数(从29±6升至36±8,而硝普钠组从29±6升至30±6毫升/平方米,p = 0.02),以及右心室射血分数(从30±8%升至42±7%,而硝普钠组从34±8%升至37±4%,p<0.01)。我们得出结论,尽管心脏充盈压升高,但容量负荷并不能改善急性RVMI患者的心脏指数,且在适当的容量负荷后,多巴酚丁胺输注比硝普钠输注能使心脏指数和右心室射血分数有显著改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验